BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8382466)

  • 1. [The role of autocrine motility factor receptor in metastasis].
    Watanabe H; Chigira M; Raz A
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
    Nabi IR; Watanabe H; Raz A
    Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell autocrine motility factor receptor.
    Nabi IR; Watanabe H; Silletti S; Raz A
    EXS; 1991; 59():163-77. PubMed ID: 1655517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
    Lotan R; Amos B; Watanabe H; Raz A
    Cancer Res; 1992 Sep; 52(18):4878-84. PubMed ID: 1325286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
    Silletti S; Timar J; Honn KV; Raz A
    Cancer Res; 1994 Nov; 54(22):5752-6. PubMed ID: 7954394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine motility factor is a growth factor.
    Silletti S; Raz A
    Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
    Watanabe H; Shinozaki T; Raz A; Chigira M
    Int J Cancer; 1993 Feb; 53(4):689-95. PubMed ID: 8382196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
    Fairbank M; St-Pierre P; Nabi IR
    Mol Biosyst; 2009 Aug; 5(8):793-801. PubMed ID: 19603112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
    Haga A; Komazaki S; Funasaka T; Hashimoto K; Yokoyama Y; Watanabe H; Raz A; Nagase H
    Leuk Lymphoma; 2006 Oct; 47(10):2234-43. PubMed ID: 17071500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of small GTPase Rho is required for autocrine motility factor signaling.
    Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
    Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
    Kojic LD; Wiseman SM; Ghaidi F; Joshi B; Nedev H; Saragovi HU; Nabi IR
    PLoS One; 2008; 3(10):e3597. PubMed ID: 18974847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
    Silletti S; Yao JP; Pienta KJ; Raz A
    Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
    Funasaka T; Haga A; Raz A; Nagase H
    Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase.
    Shankar J; Kojic LD; St-Pierre P; Wang PT; Fu M; Joshi B; Nabi IR
    J Cell Sci; 2013 Aug; 126(Pt 15):3295-304. PubMed ID: 23690547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
    Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
    Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
    Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
    Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of autocrine motility-like factor in rheumatoid synovial fluid.
    Watanabe H; Takeuchi K; Chigira M
    J Rheumatol; 1994 Jan; 21(1):37-40. PubMed ID: 8151584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm].
    Haga A
    Yakugaku Zasshi; 2005 Feb; 125(2):169-75. PubMed ID: 15684571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
    Watanabe H; Carmi P; Hogan V; Raz T; Silletti S; Nabi IR; Raz A
    J Biol Chem; 1991 Jul; 266(20):13442-8. PubMed ID: 1649192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.